FDA declines to approve Daiichi Sankyo's blood cancer treatment

FDA declines to approve Daiichi Sankyo's blood cancer treatment

Submitted by admin on June 21, 2019 - 11:55pm
Source: 
Reuters
News Tags: 
Daiichi Sankyo
FDA
quizartinib
acute myeloid leukemia
Headline: 
FDA declines to approve Daiichi Sankyo's blood cancer treatment
snippet: 

Japan’s Daiichi Sankyo Co said on Friday the U.S. Food and Drug Administration has declined to approve its drug quizartinib as a treatment for adults with a type of blood cancer.

Do Not Allow Advertisers to Use My Personal information